Control of the survival and growth of human glioblastoma grafted into the spinal cord of mice by taking advantage of immunorejection

Cell Transplantation

Volumn 24, Issue 7, 2015, Pages 1299-1311

  Itakura, Go ^a   Kobayashi, Yoshiomi ^a   Nishimura, Soraya ^a   Iwai, Hiroki ^a   Takano, Morito ^a   Iwanami, Akio ^a   Toyama, Yoshiaki ^a   Okano, Hideyuki ^a   Nakamura, Masaya ^a  

^a KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Cell transplantation; Spinal cord injury; Spinal glioblastoma; Xenograft model

Indexed keywords

CD4 ANTIBODY; TACROLIMUS;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOLUMINESCENCE; C57BL 6 MOUSE; CANCER GRAFT; CANCER SURVIVAL; CELL SURVIVAL; CONTROLLED STUDY; FEMALE; GLIOBLASTOMA; GRAFT REJECTION; GRAFT SURVIVAL; HUMAN; HUMAN CELL; IMMUNOSUPPRESSIVE TREATMENT; IN VITRO STUDY; IN VIVO STUDY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SCID MOUSE; SPINAL CORD TUMOR; TUMOR GROWTH; TUMOR XENOGRAFT; ANIMAL; BAGG ALBINO MOUSE; C57BL MOUSE; CELL DIFFERENTIATION; CELL TRANSPLANTATION; DISEASE MODEL; DRUG SCREENING; NONOBESE DIABETIC MOUSE; PATHOLOGY; SPINAL CORD;

MUS; PRIMATES; RODENTIA;

ANIMALS; CELL DIFFERENTIATION; CELL TRANSPLANTATION; DISEASE MODELS, ANIMAL; FEMALE; GLIOBLASTOMA; GRAFT REJECTION; HUMANS; IMMUNOSUPPRESSION; MALE; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, INBRED NOD; MICE, SCID; SPINAL CORD; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84937399082     PISSN: 09636897     EISSN: 15553892     Source Type: Journal    
DOI: 10.3727/096368914X681711     Document Type: Article

References (46)

1. Anderson, A. J.; Haus, D. L.; Hooshmand, M. J.; Perez, H.; Sontag, C. J.; Cummings, B. J. Achieving stable human stem cell engraftment and survival in the CNS: Is the future of regenerative medicine immunodeficient? Regen. Med. 6(3):367–406; 2011.
2. Auchincloss, Jr., H.; Sachs, D. H. Xenogeneic transplantation. Annu. Rev. Immunol. 16:433–470; 1998.
3. Basso, D. M.; Fisher, L. C.; Anderson, A. J.; Jakeman, L. B.; McTigue, D. M.; Popovich, P. G. Basso Mouse Scale for locomotion detects differences in recovery after spinal cord injury in five common mouse strains. J. Neurotrauma 23(5):635–659; 2006.
4. Ben-David, U.; Benvenisty, N. The tumorigenicity of human embryonic and induced pluripotent stem cells. Nat. Rev. Cancer 11(4):268–277; 2011.
5. Carson, Sr., B. S.; Wu, Q.; Tyler, B.; Sukay, L.; Raychaudhuri, R.; DiMeco, F.; Clatterbuck, R. E.; Olivi, A.; Guarnieri, M. New approach to tumor therapy for inoperable areas of the brain: Chronic intraparenchymal drug delivery. J. Neurooncol. 60(2):151–158; 2002.
6. Cheng, F.; Ke, Q.; Chen, F.; Cai, B.; Gao, Y.; Ye, C.; Wang, D.; Zhang, L.; Lahn, B. T.; Li, W.; Xiang A. P. Protecting against wayward human induced pluripotent stem cells with a suicide gene. Biomaterials 33(11):3195–3204; 2012.
7. Cloughesy, T. F.; Cavenee, W. K.; Mischel, P. S. Glioblastoma: From molecular pathology to targeted treatment. Annu. Rev. Pathol. 9:1–25; 2014.
8. Dace, D. S.; Chen, P. W.; Niederkorn, J. Y. CD4+ T-celldependent tumour rejection in an immune-privileged environment requires macrophages. Immunology 123(3):367–377; 2008.
9. Freed, C. R.; Greene, P. E.; Breeze, R. E.; Tsai, W. Y.; DuMouchel, W.; Kao, R.; Dillon, S.; Winfield, H.; Culver, S.; Trojanowski, J. Q.; Eidelberg D.; Fahn, S. Transplantation of embryonic dopamine neurons for severe Parkinson’s disease. N. Engl. J. Med. 344(10):710–719; 2001.
10. Hara-Miyauchi, C.; Tsuji, O.; Hanyu, A.; Okada, S.; Yasuda, A.; Fukano, T.; Akazawa, C.; Nakamura, M.; Imamura, T.; Matsuzaki, Y.; Okano, H. J.; Miyawaki, A.; Okano, H. Bioluminescent system for dynamic imaging of cell and animal behavior. Biochem. Biophys. Res. Commun. 419(2):188–193; 2012.
11. Hashizume, R.; Ozawa, T.; Dinca, E. B.; Banerjee, A.; Prados, M. D.; James, C. D.; Gupta, N. A human brainstem glioma xenograft model enabled for bioluminescence imaging. J. Neurooncol. 96(2):151–159; 2010.
12. Hickey, W. F. Leukocyte traffic in the central nervous system: The participants and their roles. Semin. Immunol. 11(2):125–137; 1999.
13. Horvath-Arcidiacono, J. A.; Porter, C. M.; Bloom, E. T. Human NK cells can lyse porcine endothelial cells independent of their expression of Galalpha(1,3)-Gal and killing is enhanced by activation of either effector or target cells. Xenotransplantation 13(4):318–327; 2006.
14. Iwanami, A.; Kaneko, S.; Nakamura, M.; Kanemura, Y.; Mori, H.; Kobayashi, S.; Yamasaki, M.; Momoshima, S.; Ishii, H.; Ando, K.; Tanioka, Y.; Nomura, T.; Toyama, Y.; Okano, H. Transplantation of human neural stem cells for spinal cord injury in primates. J. Neurosci. Res. 80(2):182–190; 2005.
15. Jallo, G. I.; Penno, M.; Sukay, L.; Liu, J. Y.; Tyler, B.; Lee, J.; Carson, B. S.; Guarnieri, M. Experimental models of brainstem tumors: Development of a neonatal rat model. Childs Nerv. Syst. 21(5):399–403; 2005.
16. Jallo, G. I.; Volkov, A.; Wong, C.; Carson, Sr., B. S.; Penno, M. B. A novel brainstem tumor model: Functional and histopathological characterization. Childs Nerv. Syst. 22(12):1519–1525; 2006.
17. Kawai, H.; Yamashita, T.; Ohta, Y.; Deguchi, K.; Nagotani, S.; Zhang, X.; Ikeda, Y.; Matsuura, T.; Abe, K. Tridermal tumorigenesis of induced pluripotent stem cells transplanted in ischemic brain. J. Cereb. Blood Flow Metab. 30(8):1487–1493; 2010.
18. Kobayashi, Y.; Okada, Y.; Itakura, G.; Iwai, H.; Nishimura, S.; Yasuda, A.; Nori, S.; Hikishima, K.; Konomi, T.; Fujiyoshi, K.; Tsuji, O.; Toyama, Y.; Yamanaka, S.; Nakamura, M.; Okano, H. Pre-evaluated safe human iPSCderived neural stem cells promote functional recovery after spinal cord injury in common marmoset without tumorigenicity. PLoS One 7(12):e52787; 2012.
19. Lee, J.; Jallo, G. I.; Guarnieri, M.; Carson, Sr., B. S.; Penno, M. B. A novel brainstem tumor model: Guide screw technology with functional, radiological, and histopathological characterization. Neurosurg. Focus 18(6A):E11; 2005.
20. McDonald, J. W.; Liu, X. Z.; Qu, Y.; Liu, S.; Mickey, S. K.; Turetsky, D.; Gottlieb, D. I.; Choi, D. W. Transplanted embryonic stem cells survive, differentiate and promote recovery in injured rat spinal cord. Nat. Med. 5(12):1410–1412; 1999.
21. Miura, K.; Okada, Y.; Aoi, T.; Okada, A.; Takahashi, K.; Okita, K.; Nakagawa, M.; Koyanagi, M.; Tanabe, K.; Ohnuki, M.; Ogawa, D.; Ikeda, E.; Okano, H.; Yamanaka, S. Variation in the safety of induced pluripotent stem cell lines. Nat. Biotechnol. 27(8):743–745; 2009.
22. Miyoshi, H.; Blomer, U.; Takahashi, M.; Gage, F. H.; Verma, I. M. Development of a self-inactivating lentivirus vector. J. Virol. 72(10):8150–8157; 1998.
23. Muldoon, L. L.; Alvarez, J. I.; Begley, D. J.; Boado, R. J.; Del Zoppo, G. J.; Doolittle, N. D.; Engelhardt, B.; Hallenbeck, J. M.; Lonser, R. R.; Ohlfest, J. R.; Prat, A.; Scarpa, M.; Smeyne, R. J.; Drewes, L. R.; Neuwelt, E. A. Immunologic privilege in the central nervous system and the blood-brain barrier. J. Cereb. Blood Flow Metab. 33(1): 13–21; 2013.
24. Muto, J.; Imai, T.; Ogawa, D.; Nishimoto, Y.; Okada, Y.; Mabuchi, Y.; Kawase, T.; Iwanami, A.; Mischel, P. S.; Saya, H.; Yoshida, K.; Matsuzaki, Y.; Okano, H. RNA-binding protein Musashi1 modulates glioma cell growth through the post-transcriptional regulation of Notch and PI3 kinase/ Akt signaling pathways. PLoS One 7(3):e33431; 2012.
25. Nagai, T.; Ibata, K.; Park, E. S.; Kubota, M.; Mikoshiba, K.; Miyawaki, A. A variant of yellow fluorescent protein with fast and efficient maturation for cell-biological applications. Nat. Biotechnol. 20(1):87–90; 2002.
26. Nishimura, S.; Yasuda, A.; Iwai, H.; Takano, M.; Kobayashi, Y.; Nori, S.; Tsuji, O.; Fujiyoshi, K.; Ebise, H.; Toyama, Y.; Okano, H.; Nakamura, M. Time-dependent changes in the microenvironment of injured spinal cord affects the therapeutic potential of neural stem cell transplantation for spinal cord injury. Mol. Brain 6:3; 2013.
27. Nori, S.; Okada, Y.; Yasuda, A.; Tsuji, O.; Takahashi, Y.; Kobayashi, Y.; Fujiyoshi, K.; Koike, M.; Uchiyama, Y.; Ikeda, E.; Toyama, Y.; Yamanaka, S.; Nakamura, M.; Okano, H. Grafted human-induced pluripotent stem-cellderived neurospheres promote motor functional recovery after spinal cord injury in mice. Proc. Natl. Acad. Sci. USA 108(40):16825–16830; 2011.
28. Ogawa, Y.; Sawamoto, K.; Miyata, T.; Miyao, S.; Watanabe, M.; Nakamura, M.; Bregman, B. S.; Koike, M.; Uchiyama, Y.; Toyama, Y.; Okano, H. Transplantation of in vitroexpanded fetal neural progenitor cells results in neurogenesis and functional recovery after spinal cord contusion injury in adult rats. J. Neurosci. Res. 69(6):925–933; 2002.
29. Okada, S.; Ishii, K.; Yamane, J.; Iwanami, A.; Ikegami, T.; Katoh, H.; Iwamoto, Y.; Nakamura, M.; Miyoshi, H.; Okano, H. J.; Contag, C. H.; Toyama, Y.; Okano, H. In vivo imaging of engrafted neural stem cells: Its application in evaluating the optimal timing of transplantation for spinal cord injury. FASEB J. 19(13):1839–1841; 2005.
30. Okano, H.; Nakamura, M.; Yoshida, K.; Okada, Y.; Tsuji, O.; Nori, S.; Ikeda, E.; Yamanaka, S.; Miura, K. Steps toward safe cell therapy using induced pluripotent stem cells. Circ. Res. 112(3):523–533; 2013.
31. Ozawa, T.; Gryaznov, S. M.; Hu, L. J.; Pongracz, K.; Santos, R. A.; Bollen, A. W.; Lamborn, K. R.; Deen, D. F. Antitumor effects of specific telomerase inhibitor GRN163 in human glioblastoma xenografts. Neuro Oncol. 6(3):218–226; 2004.
32. Ozawa, T.; Santos, R. A.; Lamborn, K. R.; Bauer, W. F.; Koo, M. S.; Kahl, S. B.; Deen, D. F. In vivo evaluation of the boronated porphyrin TABP-1 in U-87 MG intracerebral human glioblastoma xenografts. Mol. Pharm. 1(5):368–374; 2004.
33. Ozawa, T.; Wang, J.; Hu, L. J.; Bollen, A. W.; Lamborn, K. R.; Deen, D. F. Growth of human glioblastomas as xenografts in the brains of athymic rats. In Vivo 16(1):55–60; 2002.
34. Oztopcu, P.; Kabadere, S.; Mercangoz, A.; Uyar, R. Comparison of vitamins K1, K2 and K3 effects on growth of rat glioma and human glioblastoma multiforme cells in vitro. Acta Neurol. Belg. 104(3):106–110; 2004.
35. Suvannavejh, G. C.; Dal Canto, M. C.; Matis, L. A.; Miller, S. D. Fas-mediated apoptosis in clinical remissions of relapsing experimental autoimmune encephalomyelitis. J. Clin. Invest. 105(2):223–231; 2000.
36. Swijnenburg, R. J.; Schrepfer, S.; Govaert, J. A.; Cao, F.; Ransohoff, K.; Sheikh, A. Y.; Haddad, M.; Connolly, A. J.; Davis, M. M.; Robbins, R. C.; Wu, J. C. Immunosuppressive therapy mitigates immunological rejection of human embryonic stem cell xenografts. Proc. Natl. Acad. Sci. USA 105(35):12991–12996; 2008.
37. Takahashi, K.; Yamanaka, S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126(4):663–676; 2006.
38. Takahashi, T.; Saadi, S.; Platt, J. L. Recent advances in the immunology of xenotransplantation. Immunologic. Res. 16(3):273–297; 1997.
39. Takahashi, Y.; Tsuji, O.; Kumagai, G.; Hara, C. M.; Okano, H. J.; Miyawaki, A.; Toyama, Y.; Okano, H.; Nakamura, M. Comparative study of methods for administering neural stem/progenitor cells to treat spinal cord injury in mice. Cell Transplant. 20(5):727–739; 2011.
40. Tokuda, K.; Bodell, W. J. Cytotoxicity and induction of sister chromatid exchanges in human and rodent brain tumor cells treated with alkylating chemotherapeutic agents. Cancer Res. 48(11):3100–3105; 1988.
41. Towner, R. A.; Gillespie, D. L.; Schwager, A.; Saunders, D. G.; Smith, N.; Njoku, C. E.; Krysiak, 3rd, R. S.; Larabee, C.; Iqbal, H.; Floyd, R. A.; Bourne, D. W.; Abdullah, O.; Hsu, E. W.; Jensen, R. L. Regression of glioma tumor growth in F98 and U87 rat glioma models by the Nitrone OKN-007. Neuro Oncol. 15(3):330–340; 2013.
42. Tsuji, O.; Miura, K.; Okada, Y.; Fujiyoshi, K.; Mukaino, M.; Nagoshi, N.; Kitamura, K.; Kumagai, G.; Nishino, M.; Tomisato, S.; Higashi, H.; Nagai, T.; Katoh, H.; Kohda, K.; Matsuzaki, Y.; Yuzaki, M.; Ikeda, E.; Toyama, Y.; Nakamura, M.; Yamanaka, S.; Okano, H. Therapeutic potential of appropriately evaluated safe-induced pluripotent stem cells for spinal cord injury. Proc. Natl. Acad. Sci. USA 107(28):12704–12709; 2010.
43. Weller, M. More on the immune privilege of glioblastoma. Neuro Oncol. 14(5):527–528; 2012.
44. Werbowetski-Ogilvie, T. E.; Morrison, L. C.; Fiebig- Comyn, A.; Bhatia, M. In vivo generation of neural tumors from neoplastic pluripotent stem cells models early human pediatric brain tumor formation. Stem Cells 30(3):392–404; 2012.
45. Wu, Q.; Tyler, B.; Sukay, L.; Rhines, L.; DiMeco, F.; Clatterbuck, R. E.; Guarnieri, M.; Carson, B. S., Sr. Experimental rodent models of brainstem tumors. Vet. Pathol. 39(3):293–299; 2002.
46. Yasuda, A.; Tsuji, O.; Shibata, S.; Nori, S.; Takano, M.; Kobayashi, Y.; Takahashi, Y.; Fujiyoshi, K.; Hara, C. M.; Miyawaki, A.; Okano, H. J.; Toyama, Y.; Nakamura, M.; Okano, H. Significance of remyelination by neural stem/ progenitor cells transplanted into the injured spinal cord. Stem Cells 29(12):1983–1994; 2011.